India's HPV vaccine drive crosses 80 lakh doses in 7 months, 4 states hit 100% coverage
Synopsis
Key Takeaways
India has crossed a landmark milestone in its fight against cervical cancer, with over 80 lakh doses of the Human Papillomavirus (HPV) vaccine administered under the National HPV Vaccination Campaign since its launch in February 2026, the Ministry of Health and Family Welfare confirmed in an official statement on 11 September 2026. The campaign, which offers free, voluntary, single-dose vaccination to 14-year-old girls at government health facilities, is now entering its final phase.
State-wise Coverage Progress
Gujarat, Uttar Pradesh, Madhya Pradesh, and Mizoram have achieved 100 per cent coverage of their identified target populations — a significant logistical achievement given the scale and geographic diversity involved. Bihar, Andhra Pradesh, and Assam have each crossed 90 per cent coverage, while Karnataka has surpassed 85 per cent. Chhattisgarh, Sikkim, Kerala, Telangana, and Odisha have crossed the 60 per cent threshold.
Notably, the progress in Assam and other Northeastern states demonstrates the effectiveness of integrated community health networks and coordinated field-level action in reaching geographically dispersed populations.
Who Is Behind the Drive
The campaign was launched by Prime Minister Narendra Modi in February 2026, making it one of the most ambitious public health initiatives of his current term. According to Registrar General of India (RGI) 2021 estimates, approximately 1.2 crore girls form the annual cohort of 14-year-olds who are expected to benefit from the initiative each year.
Healthcare providers — including paediatricians, gynaecologists, and specialists from institutions such as the All India Institute of Medical Sciences (AIIMS) — along with teachers and frontline health workers including ASHAs and ANMs, have supported awareness and community mobilisation across states and districts.
Digital Infrastructure and Safety Monitoring
The campaign has leveraged India's expanding digital health architecture through the U-WIN platform, which enables programme managers to monitor district-level vaccination coverage in real time, identify missed beneficiaries, and optimise resource allocation. All vaccination sessions are conducted under the supervision of trained medical officers at government health facilities.
Government facilities are also linked with 24×7 healthcare centres to manage rare Adverse Events Following Immunization (AEFI), ensuring timely assessment and clinical response in the event of any vaccination-related complication.
India in the Global Context
India's rapid uptake places it in the company of nations accelerating cervical cancer prevention through national immunisation frameworks. According to the ministry's statement, currently 87 per cent of upper-middle-income countries, 78 per cent of lower-middle-income countries, and 54 per cent of low-income countries have adopted HPV vaccines in their national immunisation programmes.
Cervical cancer is the second most common cancer among women in India, making the scale of this campaign a direct public health priority. The Ministry of Health and Family Welfare said it continues to work closely with states, Union Territories, and frontline workers to ensure that no eligible girl is left behind as the drive moves toward completion.